Caricamento...

Differences in reimbursement listing of anticancer therapies in China: an observational study

OBJECTIVE: Access to highly priced anticancer medications usually requires insurance coverage. A first step towards coverage of such medications is their inclusion in reimbursement lists. We assessed listing for reimbursement in China between 2009 and 2018 of anticancer medications on the WHO’s Esse...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Open
Autori principali: Guan, Xiaodong, Zhang, Yichen, Wushouer, Haishaerjiang, Shi, Luwen, Ross-Degnan, Dennis, Wagner, Anita Katharina
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6955534/
https://ncbi.nlm.nih.gov/pubmed/31911513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-031203
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !